Infliximab Infusion Therapy: A Proven Biologic for Autoimmune and Inflammatory Diseases

For patients living with autoimmune disorders like Crohn’s disease, ulcerative colitis, or rheumatoid arthritis, Infliximab infusion therapy offers targeted, long-lasting relief from inflammation and immune-related symptoms. This guide answers common questions such as “What is Infliximab?”, “How does Infliximab work?”, and “Is IV therapy effective for autoimmune conditions?”

Key Takeaways

  • Infliximab is a biologic medicine used to treat autoimmune and inflammatory diseases such as Crohn’s disease, ulcerative colitis, and rheumatoid arthritis.
  • It works by blocking tumour necrosis factor-alpha (TNF-α), reducing inflammation and slowing disease progression.
  • Administered through intravenous infusion therapy, infliximab provides targeted, long-lasting symptom relief.
  • Regular monitoring ensures treatment safety and effectiveness in a clinical setting.
  • Patients often experience fewer flare-ups, improved mobility, and a better quality of life.

How Infliximab Infusion Therapy Works

Infliximab cannot be taken as a tablet because it’s a protein-based biologic that would be destroyed during digestion. Instead, it’s given through IV infusion therapy, allowing the medicine to enter the bloodstream directly and act quickly. A typical infusion session includes:
  1. Assessment: Review of medical history and current health status
  2. IV Setup: Insertion of an IV line, usually in the arm or hand
  3. Administration: Controlled infusion of Infliximab over 2–3 hours
  4. Monitoring: Continuous observation by medical staff for comfort and safety
According to the NHS , infliximab is an established, evidence-based treatment for several autoimmune disorders and is administered under close medical supervision.

Benefits of Infliximab IV Therapy

Patients receiving infliximab often experience

  • Reduction in pain and swelling
  • Fewer relapses or disease flare-ups
  • Improved joint and muscle mobility 
  • Slower disease progression 
  • Enhanced overall wellbeing

Autoimmune & Inflammatory  Conditions Treated with Infliximab

Infliximab is approved for a range of autoimmune and inflammatory conditions, including  The Arthritis Foundation highlights infliximab’s role as one of the most effective TNF inhibitors for reducing inflammation in autoimmune arthritis.

Side-Effects of Infliximab and Safety

Infliximab is generally well-tolerated  when administered in a clinical setting under medical supervision. Mild, short-term side effects may include:

  • Headache or fatigue
  • Low-grade fever
  • Mild nausea or redness at the injection site

Rare but serious risks: Allergic reactions or infections, which is why professional monitoring and regular lab tests are essential throughout treatment.
Routine blood tests and health assessments are part of ongoing safety monitoring to ensure optimal dosing.

What to Expect During an Infliximab Session

Frequency: Every 6–8 weeks (depending on diagnosis and response)

Duration: 2–3 hours per session

Experience: Patients relax in a recliner, read, or listen to music while nurses monitor the infusion. Most return to normal activities afterward.

Many find this approach convenient, as it reduces the need for frequent dosing and provides professional oversight at every visit.

Infliximab Infusion Therapy at IV One Infusion Centre

At IV One Infusion Centre, a trusted IV therapy centre in Riyadh, we provide expert infliximab infusion therapy in a safe and supportive setting. Our experienced clinicians design personalised treatment plans that maximise results while ensuring your comfort and safety. 

Get in touch with us today to learn more about biologic and intravenous therapy options for autoimmune and inflammatory conditions.

Frequently Asked Questions

1. What is infliximab used for?
It is prescribed for autoimmune conditions such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis, psoriasis, and ankylosing spondylitis.
Through intravenous infusion therapy in a clinic or hospital under professional supervision.
Most patients receive infusions every six to eight weeks, depending on individual response and condition severity.
Mild headache, nausea, or fatigue are common. Serious reactions are rare but closely monitored.
No, but it significantly reduces inflammation, controls symptoms, and slows disease progression.

Enquire Now